Literature DB >> 23268600

Gene expression profiling of transporters in the solute carrier and ATP-binding cassette superfamilies in human eye substructures.

Amber Dahlin1, Ethan Geier, Sophie L Stocker, Cheryl D Cropp, Elena Grigorenko, Michele Bloomer, Julie Siegenthaler, Lu Xu, Anthony S Basile, Diane D-S Tang-Liu, Kathleen M Giacomini.   

Abstract

The barrier epithelia of the cornea and retina control drug and nutrient access to various compartments of the human eye. While ocular transporters are likely to play a critical role in homeostasis and drug delivery, little is known about their expression, localization and function. In this study, the mRNA expression levels of 445 transporters, metabolic enzymes, transcription factors and nuclear receptors were profiled in five regions of the human eye: cornea, iris, ciliary body, choroid and retina. Through RNA expression profiling and immunohistochemistry, several transporters were identified as putative targets for drug transport in ocular tissues. Our analysis identified SLC22A7 (OAT2), a carrier for the antiviral drug acyclovir, in the corneal epithelium, in addition to ABCG2 (BCRP), an important xenobiotic efflux pump, in retinal nerve fibers and the retinal pigment epithelium. Collectively, our results provide an understanding of the transporters that serve to maintain ocular homeostasis and which may be potential targets for drug delivery to deep compartments of the eye.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23268600      PMCID: PMC4032224          DOI: 10.1021/mp300429e

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  102 in total

Review 1.  Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye.

Authors:  M R Prausnitz; J S Noonan
Journal:  J Pharm Sci       Date:  1998-12       Impact factor: 3.534

2.  Drug transporter and cytochrome P450 mRNA expression in human ocular barriers: implications for ocular drug disposition.

Authors:  Tao Zhang; Cathie D Xiang; David Gale; Samantha Carreiro; Ellen Y Wu; Eric Y Zhang
Journal:  Drug Metab Dispos       Date:  2008-04-14       Impact factor: 3.922

Review 3.  Membrane transporters in drug development.

Authors:  Kathleen M Giacomini; Shiew-Mei Huang; Donald J Tweedie; Leslie Z Benet; Kim L R Brouwer; Xiaoyan Chu; Amber Dahlin; Raymond Evers; Volker Fischer; Kathleen M Hillgren; Keith A Hoffmaster; Toshihisa Ishikawa; Dietrich Keppler; Richard B Kim; Caroline A Lee; Mikko Niemi; Joseph W Polli; Yuichi Sugiyama; Peter W Swaan; Joseph A Ware; Stephen H Wright; Sook Wah Yee; Maciej J Zamek-Gliszczynski; Lei Zhang
Journal:  Nat Rev Drug Discov       Date:  2010-03       Impact factor: 84.694

4.  Association of variants in the LIPC and ABCA1 genes with intermediate and large drusen and advanced age-related macular degeneration.

Authors:  Yi Yu; Robyn Reynolds; Jesen Fagerness; Bernard Rosner; Mark J Daly; Johanna M Seddon
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-06-28       Impact factor: 4.799

5.  HNF4alpha and NF-E2 are key transcriptional regulators of the murine Abcc6 gene expression.

Authors:  Vanessa Douet; Christopher M VanWart; Matthew B Heller; Sabrina Reinhard; Olivier Le Saux
Journal:  Biochim Biophys Acta       Date:  2006-08-11

6.  Expression and immunolocalization of the plasma membrane monoamine transporter in the brain.

Authors:  A Dahlin; L Xia; W Kong; R Hevner; J Wang
Journal:  Neuroscience       Date:  2007-04-03       Impact factor: 3.590

7.  Molecular genetic basis for fluoroquinolone-induced retinal degeneration in cats.

Authors:  Christina J Ramirez; Jonathan D Minch; John M Gay; Sunshine M Lahmers; Dan J Guerra; Gary J Haldorson; Terri Schneider; Katrina L Mealey
Journal:  Pharmacogenet Genomics       Date:  2011-02       Impact factor: 2.089

8.  Roles of inner blood-retinal barrier organic anion transporter 3 in the vitreous/retina-to-blood efflux transport of p-aminohippuric acid, benzylpenicillin, and 6-mercaptopurine.

Authors:  Ken-ichi Hosoya; Akihide Makihara; Yuki Tsujikawa; Daisuke Yoneyama; Shinobu Mori; Tetsuya Terasaki; Shin-ichi Akanuma; Masatoshi Tomi; Masanori Tachikawa
Journal:  J Pharmacol Exp Ther       Date:  2008-12-30       Impact factor: 4.030

9.  Lipids, lipoproteins, and age-related macular degeneration.

Authors:  Katayoon B Ebrahimi; James T Handa
Journal:  J Lipids       Date:  2011-07-28

10.  Three novel ABCC5 splice variants in human retina and their role as regulators of ABCC5 gene expression.

Authors:  Jelena Stojic; Heidi Stöhr; Bernhard H F Weber
Journal:  BMC Mol Biol       Date:  2007-05-23       Impact factor: 2.946

View more
  18 in total

1.  A renal-like organic anion transport system in the ciliary epithelium of the bovine and human eye.

Authors:  Jonghwa Lee; Mohammad Shahidullah; Adam Hotchkiss; Miguel Coca-Prados; Nicholas A Delamere; Ryan M Pelis
Journal:  Mol Pharmacol       Date:  2015-02-06       Impact factor: 4.436

Review 2.  The organic anion transporter (OAT) family: a systems biology perspective.

Authors:  Sanjay K Nigam; Kevin T Bush; Gleb Martovetsky; Sun-Young Ahn; Henry C Liu; Erin Richard; Vibha Bhatnagar; Wei Wu
Journal:  Physiol Rev       Date:  2015-01       Impact factor: 37.312

Review 3.  Drug transporters in the central nervous system.

Authors:  Bruno Stieger; Bo Gao
Journal:  Clin Pharmacokinet       Date:  2015-03       Impact factor: 6.447

4.  In vitro models of molecular and nano-particle transport across the blood-brain barrier.

Authors:  Cynthia Hajal; Marco Campisi; Clara Mattu; Valeria Chiono; Roger D Kamm
Journal:  Biomicrofluidics       Date:  2018-05-31       Impact factor: 2.800

Review 5.  Ocular cytochrome P450s and transporters: roles in disease and endobiotic and xenobiotic disposition.

Authors:  Mariko Nakano; Catherine M Lockhart; Edward J Kelly; Allan E Rettie
Journal:  Drug Metab Rev       Date:  2014-05-26       Impact factor: 4.518

Review 6.  Transporters in Drug Development: 2018 ITC Recommendations for Transporters of Emerging Clinical Importance.

Authors:  Maciej J Zamek-Gliszczynski; Mitchell E Taub; Paresh P Chothe; Xiaoyan Chu; Kathleen M Giacomini; Richard B Kim; Adrian S Ray; Sophie L Stocker; Jashvant D Unadkat; Matthias B Wittwer; Cindy Xia; Sook-Wah Yee; Lei Zhang; Yan Zhang
Journal:  Clin Pharmacol Ther       Date:  2018-08-08       Impact factor: 6.875

Review 7.  Ocular barriers as a double-edged sword: preventing and facilitating drug delivery to the retina.

Authors:  Lixiang Wang; Hui Zhang
Journal:  Drug Deliv Transl Res       Date:  2022-09-21       Impact factor: 5.671

8.  Molecular Mechanisms for Species Differences in Organic Anion Transporter 1, OAT1: Implications for Renal Drug Toxicity.

Authors:  Ling Zou; Adrian Stecula; Anshul Gupta; Bhagwat Prasad; Huan-Chieh Chien; Sook Wah Yee; Li Wang; Jashvant D Unadkat; Simone H Stahl; Katherine S Fenner; Kathleen M Giacomini
Journal:  Mol Pharmacol       Date:  2018-05-02       Impact factor: 4.436

9.  Metabolomic and Genome-wide Association Studies Reveal Potential Endogenous Biomarkers for OATP1B1.

Authors:  S W Yee; M M Giacomini; C-H Hsueh; D Weitz; X Liang; S Goswami; J M Kinchen; A Coelho; A A Zur; K Mertsch; W Brian; D L Kroetz; K M Giacomini
Journal:  Clin Pharmacol Ther       Date:  2016-09-20       Impact factor: 6.875

10.  Blood-brain and retinal barriers show dissimilar ABC transporter impacts and concealed effect of P-glycoprotein on a novel verapamil influx carrier.

Authors:  Hélène Chapy; Bruno Saubaméa; Nicolas Tournier; Fanchon Bourasset; Francine Behar-Cohen; Xavier Declèves; Jean-Michel Scherrmann; Salvatore Cisternino
Journal:  Br J Pharmacol       Date:  2016-01-15       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.